Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BILINASDAQ:HQYNASDAQ:PINCNASDAQ:QXO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBILIBilibili$21.38-0.3%$18.90$12.72▼$31.77$8.95B0.896.05 million shs12,232 shsHQYHealthEquity$105.43+0.5%$98.50$65.01▼$116.65$9.01B0.49852,380 shs997,185 shsPINCPremier$21.84+1.1%$22.19$17.23▼$23.56$1.80B0.571.27 million shs1.69 million shsQXOQXO$21.58+0.2%$17.30$10.61▼$157.28$12.50B2.383.89 million shs47,545 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBILIBilibili+0.14%+7.73%+18.05%+12.95%+38.92%HQYHealthEquity-0.11%+3.51%+3.61%+20.34%+21.53%PINCPremier+1.48%+0.18%-5.11%+12.58%+17.46%QXOQXO+3.72%-10.47%+26.39%+51.96%+2,153,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBILIBilibili2.2659 of 5 stars1.55.00.00.02.41.71.9HQYHealthEquity3.5576 of 5 stars3.53.00.00.02.22.51.9PINCPremier2.2425 of 5 stars1.03.02.50.02.42.51.9QXOQXO3.4934 of 5 stars4.61.00.00.03.12.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBILIBilibili 2.92Moderate Buy$21.621.13% UpsideHQYHealthEquity 3.00Buy$118.0912.01% UpsidePINCPremier 2.00Hold$22.201.64% UpsideQXOQXO 3.20Buy$34.3359.13% UpsideCurrent Analyst Ratings BreakdownLatest PINC, HQY, BILI, and QXO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/1/2025QXOQXOTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$30.006/18/2025QXOQXOWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform6/12/2025QXOQXOBaird R WSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy6/12/2025QXOQXORobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$32.006/11/2025QXOQXOOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$27.006/6/2025QXOQXOWolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$44.006/5/2025HQYHealthEquityBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$112.00 ➝ $125.006/5/2025HQYHealthEquityDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$98.00 ➝ $115.006/4/2025HQYHealthEquityThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$94.00 ➝ $104.006/4/2025HQYHealthEquityRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$112.00 ➝ $117.006/4/2025HQYHealthEquityJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Outperform ➝ Market Outperform$110.00 ➝ $117.00(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBILIBilibili$3.68B2.43$0.45 per share47.41$4.64 per share4.61HQYHealthEquity$1.20B7.60$4.29 per share24.60$24.40 per share4.32PINCPremier$1.35B1.34$3.68 per share5.94$18.68 per share1.17QXOQXO$55.95M223.01$0.14 per share150.78$11.37 per share1.90Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBILIBilibili-$184.51M-$0.20N/A47.51N/A-2.15%-2.59%-1.12%8/28/2025 (Estimated)HQYHealthEquity$96.70M$1.3776.0837.121.619.80%11.01%6.77%9/2/2025 (Estimated)PINCPremier$119.54M$0.5738.4016.42N/A5.68%8.79%4.86%8/19/2025 (Estimated)QXOQXO-$1.07M-$10.05N/A134.844.0930.08%1.58%1.30%8/13/2025 (Estimated)Latest PINC, HQY, BILI, and QXO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/3/2025Q1 2026HQYHealthEquity$0.81$0.97+$0.16$0.61$322.25 million$330.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBILIBilibiliN/AN/AN/AN/AN/AHQYHealthEquityN/AN/AN/AN/AN/APINCPremier$0.843.85%N/A147.37%N/AQXOQXON/AN/AN/AN/AN/ALatest PINC, HQY, BILI, and QXO DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/24/2025PINCPremierquarterly$0.214.2%5/30/20256/1/20256/15/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBILIBilibili0.231.361.36HQYHealthEquity0.504.064.06PINCPremierN/A0.650.65QXOQXON/A258.64258.64Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBILIBilibili16.08%HQYHealthEquity99.55%PINCPremier74.41%QXOQXO58.68%Insider OwnershipCompanyInsider OwnershipBILIBilibili22.20%HQYHealthEquity1.50%PINCPremier0.96%QXOQXO51.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBILIBilibili8,088417.99 million325.19 millionOptionableHQYHealthEquity3,12086.47 million85.18 millionOptionablePINCPremier2,90082.34 million81.55 millionOptionableQXOQXO195578.27 million199.39 millionOptionablePINC, HQY, BILI, and QXO HeadlinesRecent News About These CompaniesSummit Trail Advisors LLC Has $2.39 Million Stock Position in QXO, Inc. (NASDAQ:QXO)1 hour ago | marketbeat.comTruist Financial Initiates Coverage on QXO (NASDAQ:QXO)2 hours ago | marketbeat.comHome Depot Subsidiary to Acquire GMS for $5.5 Billion, Outbidding Rival QXOJune 30 at 6:36 PM | msn.comJim Cramer on QXO: “I am Going With Brad Jacobs”June 30 at 1:56 PM | insidermonkey.comWall Street Analysts Predict a 65.61% Upside in QXO INC (QXO): Here's What You Should KnowJune 30 at 10:56 AM | zacks.comQXO, Inc. (NASDAQ:QXO) Shares Bought by Oppenheimer & Co. Inc.June 29 at 3:31 AM | marketbeat.comQXO, Inc. (QXO) Offers to Acquire GMS Inc (GMS)June 28 at 6:34 AM | insidermonkey.comQXO leader Jacobs to deliver keynote at NAW Innovators SummitJune 27, 2025 | supplyht.comSQXO (QXO) Falls 7.23% After $2-Billion Share SaleJune 26, 2025 | insidermonkey.comQXO seeks US$2bil in share saleJune 26, 2025 | thestar.com.myTQXO Stock Falls After Pricing of Public OfferingJune 25, 2025 | marketwatch.comQXO (NASDAQ:QXO) Shares Gap Down - What's Next?June 25, 2025 | marketbeat.comRaymond James downgrades GMS Inc. stock amid possible takeover speculationJune 25, 2025 | investing.comBillionaire Jacobs’ QXO Seeks $2 Billion in Share SaleJune 24, 2025 | msn.comQXO Announces Pricing of Common Stock OfferingJune 24, 2025 | businesswire.comQXO Announces Common Stock OfferingJune 24, 2025 | businesswire.comPraxis Investment Management Inc. Makes New Investment in QXO, Inc. (NASDAQ:QXO)June 24, 2025 | marketbeat.comAnalysts dig into the potential race between QXO and Home Depot to buy GMSJune 23, 2025 | msn.comWhat is William Blair's Estimate for QXO Q2 Earnings?June 23, 2025 | marketbeat.comGMS Stock Skyrockets As Suitors Jockey To Buy ItJune 22, 2025 | talkmarkets.comQXO Inc.(QXO) Soars 21% W/W on GMS BidJune 22, 2025 | insidermonkey.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesChime’s Smart IPO: Half the Valuation, Double the StrengthBy Jeffrey Neal Johnson | June 18, 2025View Chime’s Smart IPO: Half the Valuation, Double the StrengthIs D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker?By Nathan Reiff | June 16, 2025View Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker?The Boring Is Beautiful Portfolio: 3 Stocks for a Worried WorldBy Jeffrey Neal Johnson | June 22, 2025View The Boring Is Beautiful Portfolio: 3 Stocks for a Worried WorldUPS Is Outpacing the Market: A Green Light for Investors?By Jeffrey Neal Johnson | June 27, 2025View UPS Is Outpacing the Market: A Green Light for Investors?Intel's Price Spikes: Noise, or the First Notes of a Turnaround?By Jeffrey Neal Johnson | June 13, 2025View Intel's Price Spikes: Noise, or the First Notes of a Turnaround?PINC, HQY, BILI, and QXO Company DescriptionsBilibili NASDAQ:BILI$21.38 -0.07 (-0.33%) As of 09:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Bilibili Inc. provides online entertainment services for the young generations in the People's Republic of China. It offers a range of digital content, including professional user generated videos, mobile games, and value-added services, such as live broadcasting, occupationally generated videos, audio drama on Maoer, and comics on Bilibili Comic. The company also provides advertising services; and IP derivatives and other services. In addition, it engages in the business and technology development activities; e-commerce business; and video, comics, and game distribution activities. Bilibili Inc. was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.HealthEquity NASDAQ:HQY$105.42 +0.55 (+0.52%) As of 09:33 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.Premier NASDAQ:PINC$21.84 +0.23 (+1.07%) As of 09:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; and STOCKD, an e-commerce platform, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is based in Charlotte, North Carolina.QXO NASDAQ:QXO$21.58 +0.04 (+0.16%) As of 09:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.QXO, Inc. operates as a business application, technology, and consulting company in North America. The company provides solutions for accounting and business management, financial reporting, enterprise resource planning, human capital management, warehouse management systems, customer relationship management, and business intelligence. It also offers value-added services that focuses on consulting and professional, specialized programming, training, and technical support services. In addition, the company provides information technology managed services, such as cybersecurity, application hosting, disaster recovery, business continuity, cloud, and other services; and data back-up, network maintenance, and upgrade services. It serves small and medium-sized businesses primarily in the manufacturing, distribution, and service industries. QXO, Inc. is headquartered in Greenwich, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Why BigBear.ai Could Rally 100% and Catch Palantir Soon Why McCormick Stock Could Soar After Durables Data Surprise Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
